Explaining lithium versus valproate and pregnancy-safe planning (CASC)

Station instructions (candidate)

You have 7 minutes. Explain recommended long-term mood stabilisation after mania, address the valproate comment from ED, outline lithium monitoring in plain language, and incorporate her pregnancy plans. Do not frighten, do not minimise teratogenicity, and do not guarantee zero risk from any option. Anchor in evidence (BALANCE, lithium suicide signal, valproate pregnancy data) and shared decision-making.[1][2][4]

Marking domains

Agenda setting and empathy; accurate plain-language explanation of bipolar maintenance; correct hierarchy that valproate is not appropriate for planned pregnancy; clear lithium benefit–monitoring trade-off; safety-net for toxicity symptoms; contraception until a preconception plan is set; invitation for partner questions. These domains mirror CASC priorities and real perinatal psychopharmacology counselling.[1][4][5][6]

Model communication map

1. Open: thank them; check understanding of bipolar I and recovery goals (stay well, work, future pregnancy).[1]
2. Valproate myth: it can treat mania, but for staying well long-term a major trial (BALANCE) found lithium worked better than valproate alone; more importantly, valproate has high risks of birth defects and learning/developmental problems for a future baby — not a good maintenance choice given her plans.[1][4][5]
3. Lithium offer: one of the best evidence-based medicines to prevent both high and low poles, and associated with lower suicide risk in studies; it needs blood tests so the dose is in a safe window.[1][2][3]
4. Monitoring demystified: kidney, thyroid and calcium checks; level about 12 hours after a dose; what symptoms mean “call us today” (vomiting, severe tremor, unsteadiness, confusion).[3][6]
5. Pregnancy timeline: reliable contraception until planned preconception review; future pregnancy on lithium is a specialist shared decision, not an automatic ban or automatic continue.[4][6]
6. Alternatives: if lithium not acceptable, discuss other options (e.g. some antipsychotics, lamotrigine for depression-heavy courses) without defaulting to valproate.[1]
7. Close: written information, blood-test logistics, crisis contacts, follow-up date.[6]

Common fails

• Endorsing valproate as “stronger and safer for pregnancy.”[4][5]
• Failing to mention BALANCE or any evidence when challenged on lithium versus valproate.[1]
• Omitting contraception counselling despite stated pregnancy plans.[4]
• Scaring the patient with inevitable kidney failure without explaining monitoring and individualised risk.[6]
• Skipping toxicity safety-net symptoms.[6]